Pharma Consult ApS Financials, key figures and credit report
Gross profit 1 148.5 kDKK FY 2025 -11.7% vs 2024
EBIT 462.7 kDKK FY 2025 -23.9% vs 2024
Net debt -1 240.8 kDKK FY 2025 -6.7% vs 2024
Quick ratio 3.1 FY 2025 -0.4 vs 2024
Income statement (kDKK)
2023 | 2024 | 2025 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | 1 454.12 | 1 300.09 | 1 148.46 |
| Employee benefit expenses | - 790.07 | - 692.05 | - 685.72 |
| EBIT | 664.05 | 608.04 | 462.74 |
| Other financial expenses | -5.47 | -12.71 | -13.76 |
| Pre-tax profit | 658.58 | 595.33 | 448.98 |
| Income taxes | - 148.63 | - 133.03 | - 105.51 |
| Net earnings | 509.94 | 462.29 | 343.47 |
Assets (kDKK)
2023 | 2024 | 2025 | |
|---|---|---|---|
| Intangible assets total | |||
| Tangible assets total | |||
| Investments total | |||
| Long term receivables total | |||
| Inventories total | |||
| Current trade debtors | 318.17 | 150.74 | 371.10 |
| Current other receivables | 4.33 | 1.10 | 8.45 |
| Current deferred tax assets | 36.88 | ||
| Short term receivables total | 322.50 | 151.84 | 416.42 |
| Cash and bank deposits | 562.25 | 1 263.60 | 1 580.71 |
| Cash and cash equivalents | 562.25 | 1 263.60 | 1 580.71 |
| Balance sheet total (assets) | 884.75 | 1 415.44 | 1 997.13 |
Equity and liabilities (kDKK)
2023 | 2024 | 2025 | |
|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 |
| Retained earnings | -0.00 | 509.94 | 972.23 |
| Profit of the financial year | 509.94 | 462.29 | 343.47 |
| Shareholders equity total | 549.94 | 1 012.23 | 1 355.70 |
| Non-current liabilities total | |||
| Current loans from credit institutions | 0.01 | 0.01 | |
| Current trade creditors | 12.01 | ||
| Current owed to participating | 4.77 | 100.61 | 339.89 |
| Short-term deferred tax liabilities | 148.63 | 133.03 | |
| Other non-interest bearing current liabilities | 169.38 | 169.55 | 301.54 |
| Current liabilities total | 334.81 | 403.20 | 641.43 |
| Balance sheet total (liabilities) | 884.75 | 1 415.44 | 1 997.13 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated